There's Reason For Concern Over ACSL Ltd.'s (TSE:6232) Massive 27% Price Jump

Those holding ACSL Ltd. (TSE:6232) shares would be relieved that the share price has rebounded 27% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. The last 30 days bring the annual gain to a very sharp 55%.

Following the firm bounce in price, you could be forgiven for thinking ACSL is a stock to steer clear of with a price-to-sales ratios (or "P/S") of 5.6x, considering almost half the companies in Japan's Electronic industry have P/S ratios below 0.6x. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.

View our latest analysis for ACSL

ps-multiple-vs-industry
TSE:6232 Price to Sales Ratio vs Industry February 18th 2025
Advertisement

How Has ACSL Performed Recently?

With revenue growth that's superior to most other companies of late, ACSL has been doing relatively well. It seems that many are expecting the strong revenue performance to persist, which has raised the P/S. If not, then existing shareholders might be a little nervous about the viability of the share price.

Want the full picture on analyst estimates for the company? Then our free report on ACSL will help you uncover what's on the horizon.

How Is ACSL's Revenue Growth Trending?

The only time you'd be truly comfortable seeing a P/S as steep as ACSL's is when the company's growth is on track to outshine the industry decidedly.

If we review the last year of revenue growth, the company posted a terrific increase of 196%. The strong recent performance means it was also able to grow revenue by 297% in total over the last three years. Accordingly, shareholders would have definitely welcomed those medium-term rates of revenue growth.

Looking ahead now, revenue is anticipated to slump, contracting by 17% during the coming year according to the sole analyst following the company. With the industry predicted to deliver 8.0% growth, that's a disappointing outcome.

With this information, we find it concerning that ACSL is trading at a P/S higher than the industry. Apparently many investors in the company reject the analyst cohort's pessimism and aren't willing to let go of their stock at any price. There's a very good chance these shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the negative growth outlook.

The Bottom Line On ACSL's P/S

Shares in ACSL have seen a strong upwards swing lately, which has really helped boost its P/S figure. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

For a company with revenues that are set to decline in the context of a growing industry, ACSL's P/S is much higher than we would've anticipated. In cases like this where we see revenue decline on the horizon, we suspect the share price is at risk of following suit, bringing back the high P/S into the realms of suitability. At these price levels, investors should remain cautious, particularly if things don't improve.

Plus, you should also learn about these 3 warning signs we've spotted with ACSL (including 1 which is significant).

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:6232

ACSL

Engages in the manufacture and sale of industrial drones in Japan and internationally.

Adequate balance sheet with low risk.

Advertisement

Weekly Picks

AN
andre_santos
RACE logo
andre_santos on Ferrari ·

Ferrari's Intrinsic and Historical Valuation

Fair Value:€243.5623.2% overvalued
12 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
TI
TibiT
COST logo
TibiT on Costco Wholesale ·

Investment Thesis: Costco Wholesale (COST)

Fair Value:US$726.2932.7% overvalued
18 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3323.3% undervalued
43 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative

Updated Narratives

WE
WealthAP
GPN logo
WealthAP on Global Payments ·

Is Global Payments (NYSE:GPN) The Undervalued Cash Cow Your Portfolio Needs?

Fair Value:US$107.1631.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
andre_santos
AVGO logo
andre_santos on Broadcom ·

Broadcom - A Fundamental and Historical Valuation

Fair Value:US$258.7135.9% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DE
Deep_Insights
HIMS logo
Deep_Insights on Hims & Hers Health ·

Hims & Hers Health aims for three dimensional revenue expansion

Fair Value:US$173.0281.9% undervalued
11 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8230.6% undervalued
78 users have followed this narrative
6 users have commented on this narrative
34 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.4% undervalued
1029 users have followed this narrative
6 users have commented on this narrative
30 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6444.1% undervalued
45 users have followed this narrative
5 users have commented on this narrative
10 users have liked this narrative
Advertisement